These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 9010691

  • 1. Progress in the prostaglandin E1-therapy of the intermittent claudication by means of bolus injections of LIPO-prostaglandin E1 (LIPO-PGE1).
    Scheffler P, Gross J, Markwirth T, Maier J, Schieffer H.
    Eur J Clin Pharmacol; 1996; 51(3-4):235-9. PubMed ID: 9010691
    [Abstract] [Full Text] [Related]

  • 2. Prostaglandin E1 -containing nanoparticles improve walking activity in an experimental rat model of intermittent claudication.
    Ishihara T, Yamashita Y, Takasaki N, Yamamoto S, Hayashi E, Tahara K, Takenaga M, Yamakawa N, Ishihara T, Kasahara T, Mizushima T.
    J Pharm Pharmacol; 2013 Aug; 65(8):1187-94. PubMed ID: 23837586
    [Abstract] [Full Text] [Related]

  • 3. Lipo-PGE1, a new lipid-encapsulated preparation of prostaglandin E1: placebo-and prostaglandin E1-controlled multicenter trials in patients with diabetic neuropathy and leg ulcers.
    Toyota T, Hirata Y, Ikeda Y, Matsuoka K, Sakuma A, Mizushima Y.
    Prostaglandins; 1993 Nov; 46(5):453-68. PubMed ID: 8278621
    [Abstract] [Full Text] [Related]

  • 4. Effects of lipo-prostaglandin E1 on wound bed microcirculation.
    Hasegawa H, Ichioka S.
    J Wound Care; 2015 Jul; 24(7):293-4, 296, 298-9. PubMed ID: 26198551
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Intracavernous injection of lipo prostaglandin E1 for the diagnosis of impotence: a comparative study with prostaglandin E1-CD].
    Yajima M, Baba K, Minagawa N, Kohno S, Haraguchi C, Iwamoto T, Osada T.
    Hinyokika Kiyo; 1993 Mar; 39(3):289-92. PubMed ID: 8506803
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of a new prostaglandin E1 regimen in outpatients with severe intermittent claudication: results of a multicenter placebo-controlled double-blind trial.
    Diehm C, Balzer K, Bisler H, Bulling B, Camci M, Creutzig A, Gruss JD, Horsch S, Odemar F, Piehler U, Rogatti W, Scheffler P, Spengel F, Treese N, Turowski A, Waldhausen P, Weber B, Weiss T.
    J Vasc Surg; 1997 Mar; 25(3):537-44. PubMed ID: 9081136
    [Abstract] [Full Text] [Related]

  • 9. Clinical efficacy of different doses of lipo-prostaglandin E1 in the treatment of painful diabetic peripheral neuropathy.
    Hong L, Zhang J, Shen J.
    J Diabetes Complications; 2015 Mar; 29(8):1283-6. PubMed ID: 26355026
    [Abstract] [Full Text] [Related]

  • 10. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease.
    Böger RH, Bode-Böger SM, Thiele W, Creutzig A, Alexander K, Frölich JC.
    J Am Coll Cardiol; 1998 Nov; 32(5):1336-44. PubMed ID: 9809945
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical effects of lipo-prostaglandin E1 in patients with delayed cerebral vasospasm].
    Korosue K, Izawa I, Hamano S, Ishida K, Kurihara E, Nagao T, Tamaki N, Matsumoto S.
    No Shinkei Geka; 1987 Jun; 15(6):635-40. PubMed ID: 3670536
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Intra-arterial infusion treatment with prostaglandin E1 in patients with intermittent claudication].
    Rudofsky G.
    Wien Klin Wochenschr; 1988 Jul 15; 100(14):484-8. PubMed ID: 3062906
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impact of a 4-week treatment with prostaglandin E1 on health-related quality of life of patients with intermittent claudication.
    Mangiafico RA, Messina R, Attinà T, Dell'Arte S, Giuliano L, Malatino LS.
    Angiology; 2000 Jun 15; 51(6):441-9. PubMed ID: 10870853
    [Abstract] [Full Text] [Related]

  • 19. Effects of regular physical training in a supervised class and additional intravenous prostaglandin E1 and naftidrofuryl infusion therapy in patients with intermittent claudication--a controlled study.
    Diehm C, Kühn A, Strauss R, Hübsch-Müller C, Kübler W.
    Vasa Suppl; 1989 Jun 15; 28():26-30. PubMed ID: 2609241
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.